Skye Bioscience Shares Are Trading Lower Amid Sympathy With Novo Nordisk After the Company Reported Results From Its Phase2a Trial of Monlunabant in Obesity.
Skye Bioscience Shares Are Trading Lower Amid Sympathy With Novo Nordisk After the Company Reported Results From Its Phase2a Trial of Monlunabant in Obesity.
Skye生物科技股份的股價出現下跌，這是由於諾和諾德公司發佈了單硫酸單聲根在肥胖症Phase2a試驗的結果，導致市場情緒低迷。
Skye Bioscience Shares Are Trading Lower Amid Sympathy With Novo Nordisk After the Company Reported Results From Its Phase2a Trial of Monlunabant in Obesity.
Skye Bioscience股票下跌，因爲其與Novo Nordisk的同情心落後。公司公佈了其在肥胖症的Phase2a試驗中使用Monlunabant後的結果。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。